Semaglutide with B12 is a compounded preparation that combines semaglutide, the active ingredient in Ozempic and Wegovy, with cyanocobalamin or methylcobalamin — forms of vitamin B12. It is not an FDA-approved product. Pharmacies and telehealth clinics began offering this combination during the 2022–2024 semaglutide shortage, often with claims that the added B12 would reduce fatigue, improve energy, or help with weight loss. The evidence for those claims is limited, and the FDA has raised specific concerns about compounded semaglutide products.
What Is in a Semaglutide With B12 Vial
A typical compounded vial contains semaglutide (2.5 mg/mL, 5 mg/mL, or another concentration chosen by the pharmacy), a B12 compound (usually cyanocobalamin), a preservative such as benzyl alcohol, a buffer, and sterile water. The patient draws a measured dose into an insulin-style syringe weekly. Unlike the pre-filled pens used for Ozempic and Wegovy, compounded vials require the patient to calculate units and measure the dose accurately.
Why B12 Is Added
Several rationales are offered by compounding pharmacies, with varying levels of evidence:
- Reducing injection-site discomfort. B12 may act as a buffering agent or mask the stinging sensation of semaglutide at compounded concentrations. This is the most commonly cited reason.
- Countering fatigue during caloric restriction. Weight loss often comes with reduced energy, and B12 is widely marketed as an energy vitamin. For patients who are not actually deficient, supplementation usually does not produce a meaningful effect.
- Marketing differentiation. A branded combination allows telehealth clinics to position their compounded product as distinct from Ozempic and Wegovy, which cannot be legally copied without a shortage declaration.
- Addressing metformin-related B12 depletion. Patients simultaneously on metformin can develop low B12 over years of use. For them, B12 supplementation is reasonable but is a metformin issue, not a semaglutide one.
What the Evidence Says
There are no randomized controlled trials showing that adding B12 to semaglutide enhances weight loss, blood sugar control, or quality of life compared with semaglutide alone. The clinical trials that led to FDA approval of Ozempic and Wegovy used semaglutide as monotherapy. The NIH Office of Dietary Supplements notes that in people who are not B12 deficient, supplementation does not improve energy, cognition, or mood above baseline.
That said, B12 has a wide safety margin. Excess is excreted in urine, and the risk of harm from the small doses in compounded preparations is low. The question is not whether B12 is dangerous but whether it is meaningful — and whether the packaged product is reliable.
Ozempic, Wegovy, Rybelsus, and Compounded With B12 Compared
| Product | Active ingredients | FDA-approved? | Typical delivery | Quality oversight |
|---|---|---|---|---|
| Ozempic | Semaglutide | Yes | Pre-filled pen | Full manufacturer standards |
| Wegovy | Semaglutide | Yes | Pre-filled pen | Full manufacturer standards |
| Rybelsus | Semaglutide (oral) | Yes | Daily tablet | Full manufacturer standards |
| Compounded semaglutide | Semaglutide | No | Multi-dose vial | State board of pharmacy |
| Compounded semaglutide + B12 | Semaglutide + cyanocobalamin | No | Multi-dose vial | State board of pharmacy |
FDA Concerns About Compounded Semaglutide
The FDA has issued multiple communications about compounded semaglutide. Reported problems include dosing errors from insulin-style syringes, unapproved salt forms (semaglutide sodium, semaglutide acetate) sold as the real drug, bacterial contamination in non-sterile production, inconsistent potency across batches, and hospitalizations for dehydration and severe hypoglycemia. Adding B12 does not change these underlying quality-control issues. The FDA’s semaglutide safety page provides the most current list of concerns.
Does Semaglutide Itself Deplete B12?
Unlike metformin, semaglutide is not recognized as a cause of B12 deficiency. The delayed gastric emptying and reduced food intake caused by semaglutide could theoretically reduce dietary B12 over long periods, but there is no strong clinical evidence of this effect at therapeutic doses. If you are on both metformin and semaglutide, periodic B12 testing is reasonable — not because of semaglutide, but because of metformin’s well-known association with low B12.
Side Effects to Watch For
The side-effect profile of semaglutide-with-B12 combinations matches that of semaglutide alone: nausea, vomiting, diarrhea, constipation, abdominal pain, and, less commonly, pancreatitis, gallbladder issues, dehydration-related acute kidney injury, and severe hypoglycemia when combined with insulin or sulfonylureas. B12 itself rarely causes side effects at supplementation doses but can cause injection-site redness or, very rarely, allergic reactions.
Questions to Ask Before Using a Compounded Product
- Is the pharmacy a state-licensed 503A facility or an FDA-registered 503B outsourcing facility?
- Is the semaglutide used the approved base form, or is it a salt (sodium, acetate)?
- What is the total concentration of semaglutide and B12 per milliliter?
- How will my dose be titrated and supervised?
- What are the storage and expiration requirements?
- Who handles adverse events and recalls?
Where This Fits in a Prediabetes Plan
Compounded GLP-1 products, with or without B12, are not first-line therapy for prediabetes. The ADA Standards of Care prioritize lifestyle change and, for selected patients, metformin. For a broader look at where medications fit, see our treatment hub. For diet and activity strategies, our diet and nutrition hub is a good starting point, and our guide on reversing prediabetes summarizes what the evidence supports.
The Bottom Line
Semaglutide with B12 is a compounded formulation — not an improved version of Ozempic or Wegovy. B12 adds little measurable benefit for patients who are not deficient, and the main safety questions center on the compounding pharmacy, not the vitamin. If you are considering any GLP-1, branded or compounded, the most important step is partnering with a clinician who can review your history, confirm there are no contraindications, and supervise dose titration.
